HGSNAT

heparan-alpha-glucosaminide N-acetyltransferase

Basic information

Region (hg38): 8:43140464-43202855

Previous symbols: [ "TMEM76" ]

Links

ENSG00000165102NCBI:138050OMIM:610453HGNC:26527Uniprot:Q68CP4AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • mucopolysaccharidosis type 3C (Definitive), mode of inheritance: AR
  • retinitis pigmentosa 73 (Moderate), mode of inheritance: AR
  • inherited retinal dystrophy (Definitive), mode of inheritance: AR
  • mucopolysaccharidosis type 3C (Strong), mode of inheritance: AR
  • mucopolysaccharidosis type 3C (Definitive), mode of inheritance: AR
  • mucopolysaccharidosis type 3C (Strong), mode of inheritance: AR
  • retinitis pigmentosa 73 (Strong), mode of inheritance: AR
  • mucopolysaccharidosis type 3 (Definitive), mode of inheritance: AR
  • retinitis pigmentosa (Supportive), mode of inheritance: AD
  • mucopolysaccharidosis type 3C (Supportive), mode of inheritance: AR
  • mucopolysaccharidosis type 3C (Definitive), mode of inheritance: AR
  • retinitis pigmentosa 73 (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Mucopolysaccharidosis type IIIC (Sanfilippo syndrome C); Retinitis pigmentosa 73ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingAudiologic/Otolaryngologic; Biochemical; Gastrointestinal; Neurologic; Ophthalmologic33384; 3142713; 16960811; 17033958; 18024218; 18518886; 19479962; 20583299; 20825431; 25859010

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the HGSNAT gene.

  • Mucopolysaccharidosis,_MPS-III-C (1113 variants)
  • Retinitis_pigmentosa_73 (1028 variants)
  • not_provided (100 variants)
  • Inborn_genetic_diseases (90 variants)
  • Retinal_dystrophy (54 variants)
  • not_specified (38 variants)
  • HGSNAT-related_disorder (21 variants)
  • Sanfilippo_syndrome (20 variants)
  • Mucopolysaccharidosis (4 variants)
  • Retinitis_pigmentosa (4 variants)
  • Intellectual_disability (3 variants)
  • Synovial_plica_syndrome (1 variants)
  • Retinal_disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the HGSNAT gene is commonly pathogenic or not. These statistics are base on transcript: NM_000152419.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
14
clinvar
326
clinvar
1
clinvar
341
missense
7
clinvar
30
clinvar
312
clinvar
18
clinvar
4
clinvar
371
nonsense
25
clinvar
19
clinvar
4
clinvar
1
clinvar
49
start loss
3
3
frameshift
38
clinvar
23
clinvar
2
clinvar
1
clinvar
64
splice donor/acceptor (+/-2bp)
14
clinvar
29
clinvar
5
clinvar
48
Total 84 101 340 346 5

Highest pathogenic variant AF is 0.00005869052

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
HGSNATprotein_codingprotein_codingENST00000379644 1862443
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1249150691249840.000276
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7062833180.8890.00001714076
Missense in Polyphen5486.3260.62553983
Synonymous0.04961261270.9940.000007431281
Loss of Function2.851836.60.4920.00000211405

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001130.00111
Ashkenazi Jewish0.000.00
East Asian0.0002820.000278
Finnish0.0003250.000325
European (Non-Finnish)0.0002230.000221
Middle Eastern0.0002820.000278
South Asian0.0002080.000196
Other0.0003310.000328

dbNSFP

Source: dbNSFP

Function
FUNCTION: Lysosomal acetyltransferase that acetylates the non- reducing terminal alpha-glucosamine residue of intralysosomal heparin or heparan sulfate, converting it into a substrate for luminal alpha-N-acetyl glucosaminidase. {ECO:0000269|PubMed:16960811, ECO:0000269|PubMed:17033958, ECO:0000269|PubMed:19823584, ECO:0000269|PubMed:20650889}.;
Disease
DISEASE: Mucopolysaccharidosis 3C (MPS3C) [MIM:252930]: A form of mucopolysaccharidosis type 3, an autosomal recessive lysosomal storage disease due to impaired degradation of heparan sulfate. MPS3 is characterized by severe central nervous system degeneration, but only mild somatic disease. Onset of clinical features usually occurs between 2 and 6 years; severe neurologic degeneration occurs in most patients between 6 and 10 years of age, and death occurs typically during the second or third decade of life. {ECO:0000269|PubMed:16960811, ECO:0000269|PubMed:17033958, ECO:0000269|PubMed:17397050, ECO:0000269|PubMed:18024218, ECO:0000269|PubMed:19479962, ECO:0000269|PubMed:19823584, ECO:0000269|PubMed:20583299, ECO:0000269|PubMed:20825431, ECO:0000269|PubMed:28101780}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 73 (RP73) [MIM:616544]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:25859010}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Lysosome - Homo sapiens (human);Glycosaminoglycan degradation - Homo sapiens (human);Neutrophil degranulation;Innate Immune System;Immune System (Consensus)

Intolerance Scores

loftool
0.388
rvis_EVS
0.16
rvis_percentile_EVS
64.82

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.666

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Gene ontology

Biological process
glycosaminoglycan catabolic process;lysosomal transport;neutrophil degranulation;protein complex oligomerization
Cellular component
lysosomal membrane;plasma membrane;integral component of membrane;specific granule membrane;tertiary granule membrane
Molecular function
heparan-alpha-glucosaminide N-acetyltransferase activity;transferase activity, transferring acyl groups
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.